Pregnancy Rating: C; Caution advised in 2nd and 3rd trimesters. Risk of intrauterine growth restriction and neonatal adverse effects including bradycardia and hypoglycemia.
Lactation risk: L3; Safety unknown
Severe renal impairment: Start at 5mg PO daily, increase by 5mg/day q2wk to max daily dose 20mg
Hepatic dosing: no adjustment
Betaxolol
Atenolol
Metaproterenol
Timolol
Methylergonovine
Phenylephrine
Isoproterenol
Acebutolol